MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2018 International Congress

    Quantitative oculomotor assessment and non-motor biomarkers in late-onset GM2 gangliosidosis

    C. Stephen, D. Balkwill, P. James, K. Sassower, J. Schmahmann, R. Lewis, F. Eichler (Boston, MA, USA)

    Objective: To assess whether quantitative eye movement measures correlate with disease severity in late-onset GM2 gangliosidosis, and to perform exploratory assessments of novel cognitive/neuropsychiatric measures…
  • 2018 International Congress

    Cognitive impairment and neuropsychological disorders in essential tremor

    J.X. Peng, N.N. LI, L. Wang, Z.J. Lu, J.Y. LI, R. Peng (Chengdu, China)

    Objective: Our research aims to investigate the characteristic of non-motor symptoms of essential tremor patients, particularly cognition and anxiety depression degree. Background: Non-motor symptoms of…
  • 2018 International Congress

    The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and analysis of relevant factors

    K. Nie, Y. Gao, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, Y. Zhang, L. Wang (Guangzhou, China)

    Objective: To investigate the clinical characteristics, cognitive impairment features, and subgroup types of Parkinson’s disease (PD) patients with mild cognitive impairment and to analyze relevant…
  • 2018 International Congress

    Hypertriglyceridemia is associated with Parkinson disease mild cognitive impairment (PD-MCI)

    S. Ng, KY. Tay, X. Huang, NSY. Chia, S. Archaryya, F. Setiawan, ZH. Lu, J. Tan, YL. Ng, MC. Wen, A. Ng, W. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: Our study aimed to characterise Parkinson disease (PD) mild cognitive impairment (PD-MCI) in early PD and to identify biomarkers associated with PD-MCI. Background: Approximately…
  • 2018 International Congress

    The comparison of three brief cognitive tests for diagnosing mild cognitive impairment in newly diagnosed Parkinson’s disease

    S. Kim, J. Jung, D. Seog (Busan, Republic of Korea)

    Objective: The aim is to compare the differences of Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) and Frontal Assessment Battery (FAB) between mild cognitive…
  • 2018 International Congress

    Cognitive networks in Parkinson’s Disease Mild Cognitive Impairment: Salience Network disruption without gray matter loss

    I. Aracil, F. Sampedro, J. Marin, J. Perez, H. Bejr-Kasem, S. Martinez-Horta, A. Horta, M. Boti, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To identify neural correlates of mild cognitive impairment in Parkinson’s disease (PD-MCI) according to Level-I Movement Disorders Task Force Criteria (MDS-TF) (1), using a…
  • 2018 International Congress

    Parkinsonism & Cognitive Dysfunction Severity Correlation in NPH with a Suggested Novel Phenotypic Subclassifcation of NPH

    A. Acharya, A. Biswas, S. Das (Kolkata, India)

    Objective: In this study, we have tried to find any correlation between severity of cognitive dysfunction and parkinsonism in NPH patients & to look for…
  • 2018 International Congress

    Comparison of Mattis and MOCA testing for neuropsychological assessment in the preoperative evaluation of subthalamic nucleus stimulation in Parkinson´s disease

    L. Prilop, M. Alsalem, A. Gulberti, C. Gerloff, C. Buhmann, W. Hamel, C. Moll, J. Köppen, M. Pötter-Nerger (Hamburg, Germany)

    Objective: The aim of the current study is to evaluate, whether 1. MOCA (Montreal Cognitive Assessment) and Mattis tests are equivalent in the detection of…
  • 2018 International Congress

    Cognitive functions are associated with tremor severity in essential tremor

    C.Y. Wei, W.K. Tsai, H.C. Lai, W.C. Chang, T. Taira (Changhua Country, Taiwan)

    Objective: To study the relationship between cognitive function and tremor severity in essential tremor Background: Essential tremor (ET) is a common neurological disorder, which characterized…
  • 2018 International Congress

    Frontal midline theta activity is reduced during cognitive control in Parkinson’s disease

    A. Singh, S. Richardson, N. Narayanan, J. Cavanagh (Iowa City, IA, USA)

    Objective: To investigate the role of frontal theta oscillation during cognitive control in Parkinson's disease (PD). Background: Mid-frontal theta activity underlies cognitive control. These 4-8…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley